Table 3.
Treatment Regimen of H. pylori Eradication
| Eradication Regimen＃ | All Patients* (n=254) | First-Treated Patients (n=108) | Re-Treatment Patients (n=146) | P value |
|---|---|---|---|---|
| AMPC + CAM, no. (%) | 59 (23.2) | 40 (37.0) | 19 (13.0) | <0.001 |
| AMPC + FLQ, no. (%) | 65 (25.6) | 36 (33.3) | 29 (19.9) | 0.015 |
| AMPC + TET, no. (%) | 62 (24.4) | 15 (13.9) | 47 (32.2) | 0.001 |
| AMPC + FZD, no. (%) | 43 (16.9) | 11 (10.2) | 32 (21.9) | 0.014 |
| Other regimens§, no. (%) | 25 (9.8) | 6 (5.6) | 19 (13.0) | 0.049 |
Notes: *Two hundred and sixty-one patients were retrospectively analyzed and 7 patients had not been treated by any regimen because 6 patients were resistant to all available antibiotics and one patient was intractable. ＃For all patients, whether they were treated for the first time or re-treated, bismuth quadruple therapy was used and the two antibiotics were shown in this Table. §Twenty-five patients were treated by other regimens, including CAM + FLQ for 5 patients, CAM + FZD for 2 patients, CAM + TET for 2 patients, FLQ + FZD for 7 patients, FLQ + TET for 5 patients, and FZD + TET for 4 patients.
Abbreviations: AMPC, amoxicillin; CAM, clarithromycin; FLQ, fluoroquinolone; FZD, Furazolidone; TET, tetracycline.